Table of Contents
Ulcers
Volume 2012, Article ID 146797, 9 pages
http://dx.doi.org/10.1155/2012/146797
Review Article

Ulcerative Lesions in Behcet's Disease

1Department of Dermatology, School of Medicine, Mersin University, 33079 Mersin, Turkey
2Department of Dermatology, Mersin State Hospital, Mersin, Turkey

Received 8 June 2012; Revised 11 September 2012; Accepted 1 October 2012

Academic Editor: Marco A. C. Frade

Copyright © 2012 Ümit Türsen and Belma Türsen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Behçet, “Uber rezidivierende aphthouse durch ein virus verursachte Geschwuere am Mund, am Auge und an den Genitalien,” Dermatologische Wochenschrift, vol. 105, pp. 1152–1157, 1937. View at Google Scholar
  2. A. Gurler, A. Boyvat, and U. Tursen, “Clinical manifestations of Behçet's disease: an analysis of 2147 patients,” Yonsei Medical Journal, vol. 38, no. 6, pp. 423–427, 1997. View at Google Scholar · View at Scopus
  3. G. Azizlerli, A. A. Kose, R. Sarica et al., “Prevalence of Behcet’s disease in Istanbul, Turkey,” International Journal of Dermatology, vol. 42, pp. 803–806, 2003. View at Publisher · View at Google Scholar
  4. U. Tursen, A. Gurler, and A. Boyvat, “Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease,” International Journal of Dermatology, vol. 42, no. 5, pp. 346–351, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Alpsoy, C. Zouboulis, and G. E. Ehrlich, “Mucocutaneous lesions of Behçet's disease,” Yonsei Medical Journal, vol. 48, no. 4, pp. 573–585, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Scheid, A. Bohadana, and Y. Martinet, “Nicotine patches for aphthous ulcers due to Behcet's syndrome,” New England Journal of Medicine, vol. 343, no. 24, pp. 1816–1817, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. M. C. Mat, N. Goksugur, B. Engin, S. Yurdakul, and H. Yazici, “The frequency of scarring after genital ulcers in Behçet's syndrome: a prospective study,” International Journal of Dermatology, vol. 45, no. 5, pp. 554–556, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Rashtak and M. Pittelkow, “Skin involvement in systemic autoimmune diseases,” Current Directions in Autoimmunity, vol. 10, pp. 344–358, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. O. Gündüz, “Histopathological evaluation of behçet's disease and identification of new skin lesions,” Pathology Research International, vol. 2012, Article ID 209316, 7 pages, 2012. View at Publisher · View at Google Scholar
  10. H. Yazici, I. Fresko, V. Hamuryudan et al., “Behçet's syndrome: the cerrahpasa experience,” Advances in Experimental Medicine and Biology, vol. 455, pp. 135–140, 1999. View at Google Scholar · View at Scopus
  11. J. W. Kim, J. H. Park, D. Lee, S. W. Hwang, and S. W. Park, “Vegetative pyoderma gangrenosum in Behçet's disease,” Acta Dermato-Venereologica, vol. 87, no. 4, pp. 365–367, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Melikoglu, E. Kural-Seyahi, K. Tascilar, and H. Yazici, “The unique features of vasculitis in Behçet's syndrome,” Clinical Reviews in Allergy and Immunology, vol. 35, no. 1-2, pp. 40–46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. O. S. Vasculopathy, “Behcet’s syndrome, and familial Mediterranean fever,” Current Opinion in Rheumatology, vol. 11, pp. 393–398, 1999. View at Publisher · View at Google Scholar
  14. I. Krause and A. Weinberger, “Behcet’s disease,” Current Opinion in Rheumatology, vol. 20, pp. 82–87, 2008. View at Publisher · View at Google Scholar
  15. U. Türsen, B. Ulubas, T. Irfan Kaya, H. Pekdemir, and G. Ikizoğlu, “Cardiac complications in Behçet's disease,” Clinical and Experimental Dermatology, vol. 27, no. 8, pp. 651–653, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. G. R. Plotkin, B. R. Patel, and V. N. Shah, “Behçet's syndrome complicated by cutaneous leukocytoclastic vasculitis. Response to prednisone and chlorambucil,” Archives of Internal Medicine, vol. 145, no. 10, pp. 1913–1915, 1985. View at Google Scholar · View at Scopus
  17. A. Vikas, S. Atul, R. Singh, L. Sarbmeet, and H. Mohan, “Behçet's disease with relapsing cutaneous polyarteritis-nodosa-like lesions, responsive to oral cyclosporine therapy,” Dermatology Online Journal, vol. 9, no. 5, p. 9, 2003. View at Google Scholar · View at Scopus
  18. S. E. Marshall, “Behçet's disease,” Best Practice and Research: Clinical Rheumatology, vol. 18, no. 3, pp. 291–311, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Evereklioglu, “Current concepts in the etiology and treatment of Behçet disease,” Survey of Ophthalmology, vol. 50, no. 4, pp. 297–350, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Andrews and D. O. Haskard, “Current management options in behçet's disease,” Minerva Medica, vol. 93, no. 5, pp. 335–345, 2002. View at Google Scholar · View at Scopus
  21. M. C. Pickering and D. O. Haskard, “Behçet's syndrome,” Journal of the Royal College of Physicians of London, vol. 34, no. 2, pp. 169–177, 2000. View at Google Scholar · View at Scopus
  22. A. Kokturk, “Clinical and pathological manifestations with differential diagnosis in Behçet's disease,” Pathology Research International, vol. 2012, Article ID 690390, 9 pages, 2012. View at Publisher · View at Google Scholar
  23. I. Krause, Y. Molad, M. Mitrani, and A. Weinberger, “Pathergy reaction in Behcet's disease: lack of correlation with mucocutaneous manifestations and systemic disease expression,” Clinical and Experimental Rheumatology, vol. 18, no. 1, pp. 71–74, 2000. View at Google Scholar · View at Scopus
  24. Ü. Gül and M. Gönül, “Oral and genital pathergy in Behçet's disease,” Dermatology, vol. 215, no. 1, pp. 80–81, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Andrews and D. O. Haskard, “Current management options in behçet's disease,” Minerva Medica, vol. 93, no. 5, pp. 335–345, 2002. View at Google Scholar · View at Scopus
  26. E. Alpsoy, L. Donmez, M. Onder et al., “Clinical features and natural course of Behçet's disease in 661 cases: a multicentre study,” British Journal of Dermatology, vol. 157, no. 5, pp. 901–906, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Alpsoy and A. Akman, “Behçet's disease: an algorithmic approach to its treatment,” Archives of Dermatological Research, vol. 301, no. 10, pp. 693–702, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Khandwala, R. G. Van Inwegen, and M. C. Alfano, “5% amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers: I. Clinical demonstration of acceleration of healing and resolution of pain,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 83, no. 2, pp. 222–230, 1997. View at Google Scholar · View at Scopus
  29. C. Tanaka, T. Matsuda, Y. Yukinari, H. Yamada, Y. Ichikawa, T. Sakane et al., “The beneficial effect of rebamipide on recurrent oral aphthous ulcers in Behcet’s disease,” in Behcet’s Disease, M. Hamza, Ed., pp. 477–480, Pub Adhoua, Tunis, Tunisia, 1997. View at Google Scholar
  30. E. Alpsoy, H. Er, C. Durusoy, and E. Yilmaz, “The use of sucralfate suspension in the treatment of oral and genital ulceration of Behcet disease: a randomized, placebo-controlled, double-blind study,” Archives of Dermatology, vol. 135, no. 5, pp. 529–532, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. M. A. G. Edres, C. Scully, and M. Gelbier, “Use of proprietary agents to relieve recurrent aphthous stomatitis,” British Dental Journal, vol. 182, no. 4, pp. 144–146, 1997. View at Google Scholar · View at Scopus
  32. N. Alli, G. Karakayali, I. Kahraman, and F. Artuz, “Local intralesional therapy with rhGM-CSF for a large genital ulcer in Behcet's disease,” British Journal of Dermatology, vol. 136, no. 4, pp. 639–640, 1997. View at Google Scholar · View at Scopus
  33. I. Kotter, H. Durk, J. Saal, G. Fierlbeck, U. Pleyer, and M. Zierhut, “Therapy of Behcet’s disease,” German Journal of Ophthalmology, vol. 5, pp. 92–97, 1996. View at Google Scholar
  34. K. E. Sharquie, R. A. Najim, W. S. Al-Dori, and R. K. Al-Hayani, “Oral zinc sulfate in the treatment of Behcet's disease: a double blind cross-over study,” Journal of Dermatology, vol. 33, no. 8, pp. 541–546, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. V. G. Kaklamani and P. G. Kaklamanis, “Treatment of behçet's disease—an update,” Seminars in Arthritis and Rheumatism, vol. 30, no. 5, pp. 299–312, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Yazici, S. Yurdakul, and V. Hamuryudan, “Behçet disease,” Current Opinion in Rheumatology, vol. 13, no. 1, pp. 18–22, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. J. M. M. Gardner-Medwin, N. J. Smith, and R. J. Powell, “Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behcet's disease: use of neurophysiological studies to detect thalidomide neuropathy,” Annals of the Rheumatic Diseases, vol. 53, no. 12, pp. 828–832, 1994. View at Google Scholar · View at Scopus
  38. P. De Merieux, L. E. Spitler, and H. E. Paulus, “Treatment of Behcet's syndrome with levamisole,” Arthritis and Rheumatism, vol. 24, no. 1, pp. 64–70, 1981. View at Google Scholar · View at Scopus
  39. I. Fresko, S. Yurdakul, V. Hamuryudan et al., “The management of Behcet's syndrome,” Annales de Medecine Interne, vol. 150, no. 7, pp. 576–581, 1999. View at Google Scholar · View at Scopus
  40. E. Aktulga, M. Altac, and A. Muftuoglu, “A double blind study of colchicine in Behcet's disease,” Haematologica, vol. 65, no. 3, pp. 399–402, 1980. View at Google Scholar · View at Scopus
  41. S. Yurdakul, C. Mat, Y. Tuzun et al., “A double-blind trial of colchicine in Behcet’s syndrome,” Arthritis and Rheumatism, vol. 44, pp. 2686–2692, 2001. View at Google Scholar
  42. S. Okten, “Penicillin in treatment of Behcet’s disease,” in Behcet’s Disease: Basic and Clinical Aspects, J. D. O’Duffy and E. Kokmen, Eds., pp. 645–648, Marcel Dekker, New York, NY, USA, 1991. View at Google Scholar
  43. I. C. Haznedaroglu, H. Demiroglu, O. I. Ozcebe, O. Ozdemir, and S. V. Dundar, “Benzathine-penicillin in the prophylaxis and treatment of Behcet’s disease,” in Proceedings of the 7th Mediterranean Congress of Rheumatology, K. A. Boki, A. A. Drosos, H. M. Moutsopoulos, A. G. Tzioufas, and P. G. Vlachoyiannopoulos, Eds., pp. 185–188, Monduzzi Editore, Athens, Greece, 1994.
  44. M. Çalgüneri, I. Ertenli, S. Kiraz, M. Erman, and I. Çelik, “Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease,” Dermatology, vol. 192, no. 2, pp. 125–128, 1996. View at Google Scholar · View at Scopus
  45. N. Oyama, M. Inoue, T. Matsui, Y. Nihei, A. Nishibu, and F. Kaneko, “Minocycline effects on the clinical symptoms in correlation with cytokines produced by peripheral blood mononuclear cells stimulated with streptococcal antigens in Behcet’s disease,” in Behcet’s Disease, M. Hamza, Ed., pp. 481–486, Pub Adhoua, Tunis, Tunisia, 1997. View at Google Scholar
  46. T. Sakane, M. Takeno, N. Suzuki, and G. Inaba, “Behcet's disease,” New England Journal of Medicine, vol. 341, no. 17, pp. 1284–1291, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Alpsoy, C. Durusoy, E. Yilmaz et al., “Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study,” Archives of Dermatology, vol. 138, no. 4, pp. 467–471, 2002. View at Google Scholar · View at Scopus
  48. H. Yazici, H. Pazarli, C. G. Barnes et al., “A controlled trial of azathioprine in Behcet's syndrome,” New England Journal of Medicine, vol. 322, no. 5, pp. 281–285, 1990. View at Google Scholar · View at Scopus
  49. D. BenEzra, E. Cohen, T. Chajek et al., “Evaluation of conventional therapy versus cyclosporine A in Behcet's syndrome,” Transplantation Proceedings, vol. 20, no. 3, pp. 136–143, 1988. View at Google Scholar · View at Scopus
  50. J. L. Jorizzo, W. L. White, C. M. Wise, M. D. Zanolli, and E. F. Sherertz, “Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behcet's disease,” Journal of the American Academy of Dermatology, vol. 24, no. 6, pp. 973–978, 1991. View at Google Scholar · View at Scopus
  51. J. L. Jorizzo, F. C. Schmalstieg, and A. R. Solomon, “Thalidomide effects in Behcet's syndrome and pustular vasculitis,” Archives of Internal Medicine, vol. 146, no. 5, pp. 878–881, 1986. View at Google Scholar · View at Scopus
  52. T. Saylan and I. Saltik, “Thalidomide in the treatment of Behcet's syndrome,” Archives of Dermatology, vol. 118, no. 8, p. 536, 1982. View at Publisher · View at Google Scholar · View at Scopus
  53. A. M. Denman, E. Graham, L. Howe, E. Y. Denman, and S. Lightman, “Low dose thalidomide treatment of Behcet’s syndrome,” in Behcet’s Disease, B. Wechsler and P. Godeau, Eds., International Congress Series, pp. 649–653, Excerpta Medica, Amsterdam, The Netherlands, 1992. View at Google Scholar
  54. P. P. Sfikakis, N. Markomichelakis, E. Alpsoy et al., “Anti-TNF therapy in the management of Behçet's disease—review and basis for recommendations,” Rheumatology, vol. 46, no. 5, pp. 736–741, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Melikoglu, I. Fresko, C. Mat et al., “Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study,” Journal of Rheumatology, vol. 32, no. 1, pp. 98–105, 2005. View at Google Scholar · View at Scopus
  56. L. Tasli, C. Mat, C. De Simone, and H. Yazici, “Lactobacilli lozenges in the management of oral ulcers of Behçet's syndrome,” Clinical and Experimental Rheumatology, vol. 24, pp. S83–S86, 2006. View at Google Scholar · View at Scopus
  57. H. Larsson, “Treatment of severe colitis in Behcet's syndrome with thalidomide (CG-217),” Journal of Internal Medicine, vol. 228, no. 4, pp. 405–407, 1990. View at Google Scholar · View at Scopus